Medicine and Dentistry
Positron Emission Tomography
100%
Polyethylene Terephthalate
54%
Neoplasm
51%
Fluorodeoxyglucose F 18
42%
Positron Emission Tomography-Computed Tomography
34%
Fluorodeoxyglucose
30%
Fluorine-18
28%
Cervical Cancer
27%
Scintigraphy
21%
Diseases
19%
Non Small Cell Lung Cancer
16%
Computer Assisted Tomography
15%
Metastatic Carcinoma
14%
Radiation Therapy
14%
Standardized Uptake Value
14%
Malignant Neoplasm
14%
Lymph Node
13%
Recurrent Disease
12%
Prostate Cancer
11%
Pelvis
11%
Colorectal Carcinoma
10%
Breast Cancer
10%
Pulmonary Embolism
9%
Overall Survival
8%
Medicare
8%
Metabolism
8%
Indium 111
8%
Technetium-99
8%
Radiology
8%
Oncology
7%
Platelet
7%
Lymph Node Metastasis
7%
Radiopharmaceutical
7%
Carcinoma
7%
Chemoradiotherapy
6%
Primary Tumor
6%
Radioactive Tracer
6%
Magnetic Resonance Imaging
6%
Biological Marker
6%
Diethylstilbestrol
6%
Cancer
6%
Radioisotope
6%
Amyloid Protein
6%
Infarction
5%
Iodine 131
5%
Estrogen Receptor
5%
Clinical Trial
5%
Surgery
5%
Carbon 11
5%
Squamous Cell Carcinoma
5%
Keyphrases
Positron Emission Tomography
80%
Fluorodeoxyglucose Positron Emission Tomography (FDG-PET)
29%
Tumor
28%
Positron Emission Tomography-computed Tomography (PET-CT)
28%
Cervical Cancer
23%
Fluorodeoxyglucose
20%
18F-fluorodeoxyglucose Positron Emission Tomography (18F-FDG PET)
17%
Standardized Uptake Value
14%
Computed Tomography
14%
SUVmax
13%
Non-small Cell Lung Cancer (NSCLC)
11%
National Oncologic PET Registry
11%
18F-fluorodeoxyglucose (18F-FDG)
10%
Radiopharmaceuticals
10%
Oncologic
10%
Cervical Carcinoma
9%
Platelets
8%
Overall Survival
8%
18F-fluoro-2-deoxy-D-glucose
8%
Fluoro
8%
American College of Radiology
8%
Scintigraphy
8%
Technetium-99m
7%
Positron
7%
Pulmonary Embolism
7%
Fluorodeoxyglucose Uptake
7%
Breast Cancer
7%
Infarction
7%
Radionuclide Imaging
7%
Metastatic Disease
7%
Metabolic Tumor Volume
6%
Primary Tumor
6%
Tumor Response
6%
Radiation Therapy
6%
Confidence Interval
6%
Liver
6%
F-18 Fluorodeoxyglucose
6%
Indium-111
6%
Colorectal Cancer
6%
Positive Predictive Value
6%
FDG Uptake
6%
Metabolic Response
5%
Radiograph
5%
Whole-body
5%
Autologous Platelet
5%
Progression-free Survival
5%
Imaging Network
5%
Initial Staging
5%
Thrombus
5%
Magnetic Resonance Imaging
5%